Andrew C. Von Eschenbach - 14 Jan 2022 Form 4 Insider Report for Radius Health, Inc. (RDUS)

Role
Director
Signature
/s/ G. Kelly Martin, as attorney-in-fact
Issuer symbol
RDUS
Transactions as of
14 Jan 2022
Transactions value $
$0
Form type
4
Date filed
25 Jan 2022, 15:31
Previous filing
02 Dec 2021
Next filing
05 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RDUS Common Stock Award $0 +5.5K $0.00 5.5K 14 Jan 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RDUS Stock Option (Right to Buy) Award $0 +10K $0.00 10K 14 Jan 2022 Common Stock 10K $6.40 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were acquired pursuant to a restricted stock unit award under the 2018 Stock Option and Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of RDUS common stock. The restricted stock units vest in full on the first anniversary of the award date, subject to continued service with RDUS through such date.
F2 This option vests in full on the first anniversary of the grant date, subject to continued service with RDUS through such date.